Want to see CON full AI Analyst Report?
Top Page
Concentra Group Holdings Parent, Inc.
(NYSE:CON)
Select Model
Select Model
Rating:68Neutral
Price Target:
$35.00
▲(10.72% Upside)
Action:Downgraded
Date:07/03/26
The score is driven primarily by solid operating performance and cash generation, reinforced by raised 2026 guidance and positive earnings-call momentum. Offsetting this are balance-sheet leverage risk and near-term technical overheating signals, while valuation support is only moderate given a ~23 P/E and low dividend yield.
Positive Factors
Free Cash Flow Strength
Reliable and material free cash flow (TTM ~ $293M) provides durable internal funding for capex, M&A, dividends and buybacks. Persistent FCF coverage near parity with net income signals quality of earnings and underpins management's ability to deleverage and invest over the next several quarters.
Negative Factors
Elevated Leverage
Material leverage volatility increases financial risk and sensitivity to cash flow swings. High absolute debt constrains strategic flexibility, raises refinancing and interest exposure, and makes sustained deleveraging essential to avoid crowding out investments or shareholder returns over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Free Cash Flow Strength
Reliable and material free cash flow (TTM ~ $293M) provides durable internal funding for capex, M&A, dividends and buybacks. Persistent FCF coverage near parity with net income signals quality of earnings and underpins management's ability to deleverage and invest over the next several quarters.
Read all positive factors
Concentra Group Holdings Parent, Inc. Key Performance Indicators (KPIs)
Any
Revenue By Segment
Data provided by:
The Fly
The FlyConcentra Group Holdings Parent, Inc. (CON) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.05B
Dividend Yield0.79%
Average Volume (3M)1.01M
Price to Earnings (P/E)22.8
Beta (1Y)0.52
Revenue Growth15.46%
EPS Growth12.13%
CountryUS
Employees13,133
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.39
Shares Outstanding127,961,780
10 Day Avg. Volume889,754
30 Day Avg. Volume1,008,042
Financial Highlights & Ratios
PEG Ratio2.05
Price to Book (P/B)6.34
Price to Sales (P/S)1.15
P/FCF Ratio12.65
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$34.14Price Target Upside8.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)1.51
Revenue Forecast (FY)$2.33B
Concentra Group Holdings Parent, Inc. Business Overview & Revenue Model
Company Description
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, ur...
How the Company Makes Money
null...
Concentra Group Holdings Parent, Inc. Earnings Call Summary
Earnings Call Date:May 07, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Positive
The call presented a broadly positive picture: revenue, visit volumes, adjusted EBITDA, margins, and free cash flow all improved materially year‑over‑year, and management raised 2026 guidance. Strategic M&A integrations (Nova and Pivot) are ahead of plan and on‑site clinic growth is accelerating. Offsetting items include modestly higher adjusted G&A tied to separation and investments, elevated absolute debt and leverage that management is working to reduce, and slower employer services growth and state rate timing/mix headwinds. Overall, the positive operational and financial momentum and raised guidance outweigh the manageable challenges.Positive Updates
Revenue Growth — Strong Start to 2026
Total company revenue of $569.6 million in Q1 2026, up 13.7% year‑over‑year versus $500.8 million. Excluding Nova and Pivot contributions, revenue was $520.3 million, a 6.3% increase versus prior year.
Negative Updates
Employer Services Growth Lagging
Employer services growth was modest compared with workers' compensation: employer services revenue grew 7.6% overall but, excluding Nova, only 3.2% year‑over‑year. Excluding Nova, employer services visits per day rose just 0.7%, and employer services remains lower contribution than workers' compensation, sensitive to low‑hire macro conditions.
Read all updates
Q1-2026 Updates
Positive
Negative
Revenue Growth — Strong Start to 2026
Total company revenue of $569.6 million in Q1 2026, up 13.7% year‑over‑year versus $500.8 million. Excluding Nova and Pivot contributions, revenue was $520.3 million, a 6.3% increase versus prior year.
Read all positive updates
Company Guidance
Management raised 2026 targets, increasing revenue guidance by $25 million to $2.275 billion–$2.375 billion and adjusted EBITDA by $10 million to $460 million–$480 million, while upping free cash flow guidance to $215 million–$235 million (low end +$15M, high end +$10M); CapEx remains $70 million–$80 million. They expect to end 2026 comfortably below 3.0x net leverage (vs. 3.4x at March) and noted trailing twelve-month adjusted EBITDA of ~$450 million; Q1 generated $21 million of operating cash flow and ~$9.9 million of free cash flow. The Board declared a $0.0625 per share dividend payable ~June 9, 2026, the company repurchased ~661k shares for $15 million in Q1 and has about $65 million remaining on its buyback authorization.Concentra Group Holdings Parent, Inc. Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
48
Neutral
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.23B | 2.16B | 1.90B | 1.84B | 1.72B |
| Gross Profit | 620.26M | 613.09M | 527.98M | 512.43M | 408.19M |
| EBITDA | 430.46M | 408.88M | 368.26M | 360.15M | 330.20M |
| Net Income | 177.99M | 172.80M | 166.54M | 179.95M | 166.73M |
Balance Sheet | |||||
| Total Assets | 2.89B | 3.04B | 2.52B | 2.49B | 2.30B |
| Cash, Cash Equivalents and Short-Term Investments | 61.70M | 79.90M | 183.25M | 31.37M | 37.66M |
| Total Debt | 2.12B | 2.10B | 1.95B | 905.00M | 1.04B |
| Total Liabilities | 2.44B | 2.62B | 2.22B | 1.31B | 1.30B |
| Stockholders Equity | 424.71M | 393.28M | 275.67M | 1.16B | 973.32M |
Cash Flow | |||||
| Free Cash Flow | 293.36M | 197.06M | 210.35M | 164.98M | 228.35M |
| Operating Cash Flow | 288.72M | 279.40M | 274.68M | 234.32M | 274.34M |
| Investing Cash Flow | -134.95M | -414.86M | -71.27M | -75.31M | -57.75M |
| Financing Cash Flow | -144.17M | 32.10M | -51.53M | -165.29M | -209.86M |
Concentra Group Holdings Parent, Inc. Technical Analysis
Positive
31.61
Price Trends
28.99
Positive
25.88
Positive
23.39
Positive
Market Momentum
0.92
Positive
64.38
Neutral
60.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CON, the sentiment is Positive. The current price of 31.61 is above the 20-day moving average (MA) of 31.55, above the 50-day MA of 28.99, and above the 200-day MA of 23.39, indicating a bullish trend. The MACD of 0.92 indicates Positive momentum. The RSI at 64.38 is Neutral, neither overbought nor oversold. The STOCH value of 60.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CON.
Concentra Group Holdings Parent, Inc. Risk Analysis
Concentra Group Holdings Parent, Inc. disclosed 63 risk factors in its most recent earnings report. Concentra Group Holdings Parent, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Concentra Group Holdings Parent, Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $25.35B | 25.41 | 11.57% | 0.97% | 6.41% | 33.31% | |
71 Outperform | $1.85B | 13.37 | 15.71% | 1.64% | ― | ― | |
68 Neutral | $4.05B | 22.77 | 46.05% | 0.79% | 15.46% | 12.13% | |
62 Neutral | $4.44B | 65.02 | 2.18% | ― | 12.15% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | $577.22M | -7.78 | -26.30% | ― | 52.54% | 2.69% | |
39 Underperform | $81.86M | -5.22 | -119.17% | ― | -19.76% | -0.17% |
* General Sector Average
CON
Concentra Group Holdings Parent, Inc.
31.65
12.02
61.22%
LH
Labcorp Holdings
309.20
48.11
18.43%
NVST
Envista Holdings
27.31
6.83
33.35%
SPAI
Safe Pro Group, Inc.
3.97
0.61
18.15%
FLOC
Flowco Holdings Inc Class A
20.45
3.60
21.35%
BBNX
Beta Bionics, Inc.
12.83
-3.59
-21.86%
Concentra Group Holdings Parent, Inc. Corporate Events
Business Operations and StrategyDividendsFinancial Disclosures
Concentra Posts Strong Q1 Results and Raises Guidance
Positive
May 7, 2026
Concentra reported strong first-quarter 2026 results on May 7, 2026, with revenue rising 13.7% year over year to $569.6 million and net income climbing 28.7% to $52.3 million, supported by higher patient visit volumes, increased revenue per visit,...
Executive/Board ChangesShareholder Meetings
Concentra Stockholders Back Board, Executive Pay and Auditor
Positive
Apr 30, 2026
On April 30, 2026, Concentra Group Holdings Parent, Inc. held its annual meeting of stockholders, at which investors elected three Class II directors — Vipin Gopal, William K. Newton and Marc R. Watkins, MD — to serve terms expiring at...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.